Trial Profile
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Apr 2023
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 07 Apr 2021 Planned End Date changed from 1 Sep 2020 to 1 Sep 2022.
- 07 Apr 2021 Planned primary completion date changed from 1 Sep 2020 to 1 Sep 2022.
- 21 Sep 2018 New trial record